Search Results - "Mencacci C"

Depression severity and concentration difficulties are independently associated with HRQOL in patients with unipolar depressive disorders.

Authors: Fattori, A. Neri, L. Bellomo, A. et al.

Source: Quality of Life Research. Sep2017, Vol. 26 Issue 9, p2459-2469. 11p. 2 Charts, 2 Graphs.

Subjects: Mental illness, Quality of life, Sociodemographic factors, Cognitive ability, Medical databases, Mental health, Mental depression, Questionnaires

Efficacy and Tolerability of Switching to Ziprasidone in Italian Patients with Acute Exacerbation of Schizophrenia: An Open-Label Trial.

Authors: Mencacci, C.¹

Source: Pharmacopsychiatry. Sep2012, Vol. 45 Issue 6, p236-240. 5p.

PMH27 Cost-Effectiveness Analysis of Depression in Italy

Authors: Katz, P. Mencacci, C. Di Sciascio, G. et al.

Source: Value in Health. Nov2012, Vol. 15 Issue 7, pA338-A338. 1p.

Efficacy and tolerability of switching from conventional and atypical antipsychotics to ziprasidone in acute schizophrenic patients

Authors: Mencacci, C. Filippo, A. Rappard, F. et al.

Source: European Psychiatry. Mar2007 Supplement 1, Vol. 22, pS136-S136. 1p.

KIR genotype and quantitative endometrial immune cell profiles in an unselected infertile population.

Authors: Varricchio, M. T. Litwitcka, K. Arrivi, C. et al.

Source: Human Reproduction. 2026 Supplement, Vol. 41, pi540-i540. 1/2p.

Estimating the Impact of Workplace Bullying: Humanistic and Economic Burden among Workers with Chronic Medical Conditions.

Authors: Fattori, A. Neri, L. Aguglia, E. et al.

Source: BioMed Research International. 10/18/2015, Vol. 2015, p1-12. 12p.

Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8-9, 2007.

Authors: Genazzani, Andrea Ricardo Gambacciani, Marco Simoncini, Tommaso et al.

Source: Gynecological Endocrinology. Aug2007, Vol. 23 Issue 8, p436-444. 9p.

Effectiveness of a social cognition remediation intervention for patients with schizophrenia: a randomized-controlled study.

Authors: Pezzella, P. Giuliani, L. Mucci, A. et al.

Source: European Psychiatry. 2025 Supplement 1, Vol. 68, pS1077-S1078. 2p.

Real-world effectiveness of long acting aripiprazole: Treatment persistence and its correlates in the Italian clinical practice.

Authors: Fagiolini, A. Aguglia, E. Ballerini, A. et al.

Source: Psychiatry Research. Feb2019, Vol. 272, p698-706. 9p.

Anti-anxiety efficacy of Sudarshan Kriya Yoga in general anxiety disorder: A multicomponent, yoga based, breath intervention program for patients suffering from generalized anxiety disorder with or without comorbidities.

Authors: Doria, S. de Vuono, A. Sanlorenzo, R. et al.

Source: Journal of Affective Disorders. Sep2015, Vol. 184, p310-317. 8p.

PMH25 Cost and Use of Resources in Patients with Schizophrenia and Bipolar Disorder Switching from Immediate Release Quetiapine (QTP-IR) to Extended Release Quetiapine (QTP-XR) in Italy- the IBIS Study

Authors: Degli Esposti, L. La Tour, F. Mencacci, C. et al.

Source: Value in Health. pA86-A86. 1p.

Italian Study on Depressive Disorders (STudio Italiano MAlattia Depressiva, or STIMA-D): A Nationwide Snapshot of the Status of Treatment for Major Depression.

Authors: Aguglia, E. Biggio, G. Signorelli, M. S. et al.

Source: Pharmacopsychiatry. May2014, Vol. 47 Issue 3, p105-110. 6p.

P.1.i.020 Psychopathology during pregnancy and postpartum: characterization of a selected high risk Italian sample

Authors: Petrilli, G. Anniverno, R. Mencacci, C. et al.

Source: European Neuropsychopharmacology. Sep2009 Supplement 3, Vol. 19, pS347-S348. 0p.

Are 'social drugs' (tobacco, coffee and chocolate) related to the bipolar spectrum?

Authors: Maremmani I Perugi G Rovai L et al.

Source: Journal of Affective Disorders. Sep2011, Vol. 133 Issue 1/2, p227-233. 7p.

Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels.

Authors: Volonteri, L. S. Colasanti, A. Cerveri, G. et al.

Source: Journal of Psychopharmacology. Aug2010, Vol. 24 Issue 8, p1193-1199. 7p.

Effects of treatment with etizolam 0.5 mg BID on cognitive performance: a 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder.

Authors: De Candia MP Di Sciascio G Durbano F et al.

Source: Clinical Therapeutics. Dec2009, Vol. 31 Issue 12, p2851-2859. 9p.

PMH17 Healthcare Resource Utilization and Related Costs of Patients Affected By Treatment-Resistant Depression in Italy.

Authors: Perrone, V. Sangiorgi, D. Andretta, M. et al.

Source: Value in Health. 2020 Supplement 2, Vol. 23, pS587-S587. 1p.

PMH29 - The Cost of Cognitive Impairment in Patient with Major Depressive Disorder.

Authors: Coretti, S Izzo, G Vaggi, M et al.

Source: Value in Health. Nov/Dec2016, Vol. 19 Issue 7, pA526-A526. 1p.

P.3.b.044 - Quality of life, mental health status and service utilization in a sample of outpatients from a mental health service in northern Italy.

Authors: Cerveri, G. Gesi, C. Venturi, V. et al.

Source: European Neuropsychopharmacology. Oct2016 Supplement 2, Vol. 26, pS520-S520. 1p.

P.1.g.009 Cognitive functioning in patients with schizophrenia vs bipolar disorder: an observational study

Authors: Cerveri, G. Venturi, V. Volonteri, L.S. et al.

Source: European Neuropsychopharmacology. Sep2011 Supplement 3, Vol. 21, pS333-S334. 0p.